Study Details
A study to evaluate pre-emptive treatment for invasive candidiasis in High Risk Surgical Subjects
Clinicaltrials.gov ID
Astellas Study ID
9463-EC-0002
EudraCT ID
2008-006409-18
Condition
Fungal Infections
Phase
Phase 2
Age
18 years - N/A
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Jul 2010 - Dec 2011
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Enrollment number
252
An Exploratory Study to Compare the Efficacy and Safety of Micafungin as a Pre-emptive Treatment of Invasive Candidiasis versus Placebo in High Risk Surgical Subjects – A multicentre, randomized, double-blind study
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A study to evaluate pre-emptive treatment for invasive candidiasis in High Risk Surgical Subjects? Contact us by filling our your information to the right and we’ll respond to you.